+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06424327

International Registry Tracking Outcomes After Pulmonary Segmentectomy for Lung Cancer

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-09-24

600

Participants Needed

20

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are observing adults with lung cancer, specifically those planned for pulmonary segmentectomy, to understand outcomes after surgery. The study focuses on patients with clinical Stage I suspected non-small cell lung cancer NSCLC and aims to track disease-free survival over 3 and 5 years following surgery. This international registry collects real-world data to provide insights on this surgical approach. Participants undergo planned pulmonary segmentectomy for primary lung cancer. Patient-reported outcomes will be gathered using the Patient-Reported Outcomes Measurement Information System PROMIS, which evaluates physical function, pain interference, and dyspnea severity through web-based surveys. These assessments occur before surgery, between 2 to 4 weeks after surgery, and again 6 months post-surgery. Throughout the study, participants complete questionnaires at specified intervals to report on their health status. The research team will measure 3-year and 5-year disease-free survival rates following segmentectomy. The study spans several years, with the primary completion date in 2029, allowing long-term monitoring of participant outcomes and health progression.

CONDITIONS

Brief Title

A Registry for People With Lung Cancer

Research Team

D

David Jones, MD

B

Bernard Park, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here